Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | UDP-galactopyranose mutase Glf | 0.0583 | 0.7088 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 0.5 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0258 | 0.2786 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.01 | 0.0687 | 0.1659 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0299 | 0.3329 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0258 | 0.2786 | 0.684 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0185 | 0.1815 | 0.1656 |
Mycobacterium tuberculosis | UDP-galactopyranose mutase Glf (UDP-GALP mutase) (NAD+-flavin adenine dinucleotide-requiring enzyme) | 0.0583 | 0.7088 | 1 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0146 | 0.1303 | 0.1612 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0179 | 0.1731 | 0.0703 |
Mycobacterium leprae | Probable UDP-galactopyranose mutase Glf (UDP-galp mutase) (NAD+-flavin adenine dinucleotide-requiring enzyme) | 0.0583 | 0.7088 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0258 | 0.2786 | 0.684 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 0.0191 | 0.7066 |
Loa Loa (eye worm) | hypothetical protein | 0.0234 | 0.2468 | 0.8738 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0169 | 0.161 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0146 | 0.1303 | 0.1612 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0253 | 0.2717 | 0.9753 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0234 | 0.2468 | 0.2322 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0062 | 0.0191 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0258 | 0.2786 | 0.684 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0062 | 0.0191 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0179 | 0.1731 | 0.0703 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0253 | 0.2717 | 0.9726 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0185 | 0.1815 | 0.7131 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0258 | 0.2786 | 0.684 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0299 | 0.3329 | 1 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0258 | 0.2786 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0258 | 0.2786 | 0.684 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0258 | 0.2786 | 0.684 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0068 | 0.027 | 0.0968 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0234 | 0.2468 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.01 | 0.0687 | 0.2467 |
Brugia malayi | hypothetical protein | 0.0234 | 0.2468 | 0.886 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0299 | 0.3329 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 0.0191 | 0.7066 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.027 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.